GFP Reporter Cell Line - SU-DHL-1

The SU-DHL-1 cell line engineered to express green fluorescent protein (GFP) is a powerful tool in various fields of biomedical research. Here are some of its major applications: Cancer research: SU-DHL-1 is a human diffuse large B-cell lymphoma (DLBCL) cell line. The introduction of GFP enables real-time visualization and tracking of tumor cell proliferation, invasion, and development in vitro and in vivo. This is particularly useful for studying mechanisms of lymphoma progression and testing the efficacy of anticancer drugs. Drug screening and development: Researchers can use the GFP-expressing SU-DHL-1 cell line to perform high-throughput screening of potential therapeutic compounds. The fluorescent tag can easily identify the effects of drugs on cell viability, growth, and apoptosis, thereby accelerating the drug discovery process. Gene expression studies: GFP acts as a reporter gene, allowing scientists to monitor the activity of other genes of interest. This makes it possible to study gene regulation, signaling pathways, and gene modifications in lymphoma cells. It helps dissect molecular pathways implicated in cancer and helps identify new molecular targets for treatment. In vivo imaging: Cells expressing GFP can be implanted into animal models and tumor growth and metastasis can be monitored in real time using fluorescence imaging techniques. This application is critical for understanding tumor biology in a physiological context and for preclinical evaluation of anticancer therapies. Cell tracking and migration studies: The fluorescence of GFP allows for detailed studies of cell migration and localization. In the context of lymphoma, it allows researchers to track the movement of cancer cells within tissues and understand how they spread in vivo. This information is critical for developing strategies to prevent metastasis. Protein interaction studies: GFP-tagged proteins can be used to study protein-protein interactions within SU-DHL-1 cells. This can help identify key proteins involved in the pathogenesis of lymphoma and potentially discover new therapeutic targets.